eMedicine Specialties > Cardiology > Electrophysiology Procedures

Catheter Ablation: Multimedia

Author: Mark Lloyd Greenberg, MD, Director, Clinical Electrophysiology and Pacing, Director, Clinical Cardiac Electrophysiology Training Program, Dartmouth-Hitchcock Medical Center; Associate Professor of Medicine, Dartmouth Medical School
Coauthor(s): Arvind Chandrakantan, MBBS, MD, Anesthetic Fellow, Department of Pediatric Anesthesiology, Cincinnati Children's Medical Center
Contributor Information and Disclosures

Updated: Oct 14, 2008

Multimedia

Diagrammatic schema of the typical type of atriov...Media file 1: Diagrammatic schema of the typical type of atrioventricular nodal reentrant tachycardia (AVNRT). The slow pathway (dashed arrow) is the usual antegrade limb of the reentry circuit and the usual ablation target area (shaded). The fast pathway (solid arrow) is the usual retrograde limb of the reentry circuit and commonly activates the atria simultaneously with ventricular activation, producing the typical ECG finding of AVNRT shown below. The P wave is not visible because it is buried in the QRS complex. Infrequently, the reentry circuit is reversed, with antegrade conduction over the fast pathway and retrograde conduction over the slow pathway, producing the atypical ECG finding of AVNRT shown below (ie, long R-P tachycardia, in which the interval between the QRS complex and retrograde P wave is longer than the subsequent P-R interval, and the P wave is in the second half of the R-R interval). The fast pathway is close to the compact atrioventricular node, and ablation in this area is avoided if possible because of the risk of iatrogenic heart block.
Diagrammatic schema of the typical type of atriov...

Diagrammatic schema of the typical type of atrioventricular nodal reentrant tachycardia (AVNRT). The slow pathway (dashed arrow) is the usual antegrade limb of the reentry circuit and the usual ablation target area (shaded). The fast pathway (solid arrow) is the usual retrograde limb of the reentry circuit and commonly activates the atria simultaneously with ventricular activation, producing the typical ECG finding of AVNRT shown below. The P wave is not visible because it is buried in the QRS complex. Infrequently, the reentry circuit is reversed, with antegrade conduction over the fast pathway and retrograde conduction over the slow pathway, producing the atypical ECG finding of AVNRT shown below (ie, long R-P tachycardia, in which the interval between the QRS complex and retrograde P wave is longer than the subsequent P-R interval, and the P wave is in the second half of the R-R interval). The fast pathway is close to the compact atrioventricular node, and ablation in this area is avoided if possible because of the risk of iatrogenic heart block.

The pseudo S waves inferiorly (compare this to th...Media file 2: The pseudo S waves inferiorly (compare this to the sinus rhythm ECG in Image 3) are retrograde P waves. This short interval between the QRS complex and the retrograde P wave is highly specific for atrioventricular nodal reentrant tachycardia (AVNRT). A pseudo R wave in V1 may also be observed, but this is not shown here. In many instances, the retrograde P wave occurs during QRS activation and is not observed; this "no-P-wave" tachycardia (see Media file 1) also suggests AVNRT.
The pseudo S waves inferiorly (compare this to th...

The pseudo S waves inferiorly (compare this to the sinus rhythm ECG in Image 3) are retrograde P waves. This short interval between the QRS complex and the retrograde P wave is highly specific for atrioventricular nodal reentrant tachycardia (AVNRT). A pseudo R wave in V1 may also be observed, but this is not shown here. In many instances, the retrograde P wave occurs during QRS activation and is not observed; this "no-P-wave" tachycardia (see Media file 1) also suggests AVNRT.

Sinus rhythm in a patient with atrioventricular n...Media file 3: Sinus rhythm in a patient with atrioventricular nodal reentrant tachycardia.
Sinus rhythm in a patient with atrioventricular n...

Sinus rhythm in a patient with atrioventricular nodal reentrant tachycardia.

Schema of orthodromic reciprocating tachycardia (...Media file 4: Schema of orthodromic reciprocating tachycardia (ORT). The atrioventricular node serves as the antegrade limb, whereas an accessory pathway (atrioventricular connection) serves as the retrograde limb. For ECG features of ORT, see Media file 5.
Schema of orthodromic reciprocating tachycardia (...

Schema of orthodromic reciprocating tachycardia (ORT). The atrioventricular node serves as the antegrade limb, whereas an accessory pathway (atrioventricular connection) serves as the retrograde limb. For ECG features of ORT, see Media file 5.

Supraventricular tachycardia (SVT) in a patient w...Media file 5: Supraventricular tachycardia (SVT) in a patient with orthodromic reciprocating tachycardia (ORT) due to a concealed pathway. Note the retrograde P wave, seen best in lead V2, separated from the QRS complex by an isoelectric baseline. (Compare to Media file 2, in which the P wave is fused to the QRS.) This pattern of "short R-P tachycardia" (in which the interval between the QRS complex and retrograde P wave is shorter than the subsequent P-R interval and the P wave is in the first half of the R-R interval) suggests an SVT incorporating an accessory pathway.
Supraventricular tachycardia (SVT) in a patient w...

Supraventricular tachycardia (SVT) in a patient with orthodromic reciprocating tachycardia (ORT) due to a concealed pathway. Note the retrograde P wave, seen best in lead V2, separated from the QRS complex by an isoelectric baseline. (Compare to Media file 2, in which the P wave is fused to the QRS.) This pattern of "short R-P tachycardia" (in which the interval between the QRS complex and retrograde P wave is shorter than the subsequent P-R interval and the P wave is in the first half of the R-R interval) suggests an SVT incorporating an accessory pathway.

Schema of the common variety of atrial flutter. T...Media file 6: Schema of the common variety of atrial flutter. The reentry circuit is confined to the right atrium and circulates as a counterclockwise macroreentrant circuit proceeding superiorly over the atrial septum and inferiorly over the lateral atrial wall. The wave front circulates through a narrow isthmus of tissue between the tricuspid valve annulus and the inferior vena cava. Linear ablation across this isthmus cures this common form of atrial flutter. For ECG features, see Media file 7.
Schema of the common variety of atrial flutter. T...

Schema of the common variety of atrial flutter. The reentry circuit is confined to the right atrium and circulates as a counterclockwise macroreentrant circuit proceeding superiorly over the atrial septum and inferiorly over the lateral atrial wall. The wave front circulates through a narrow isthmus of tissue between the tricuspid valve annulus and the inferior vena cava. Linear ablation across this isthmus cures this common form of atrial flutter. For ECG features, see Media file 7.

An example of a typical counterclockwise atrial f...Media file 7: An example of a typical counterclockwise atrial flutter, the most common form of atrial flutter. The cardinal features are a perfectly regular atrial rhythm with inverted P waves inferiorly that have a positive overshoot, upright P waves in V1, and inverted P waves in V6.
An example of a typical counterclockwise atrial f...

An example of a typical counterclockwise atrial flutter, the most common form of atrial flutter. The cardinal features are a perfectly regular atrial rhythm with inverted P waves inferiorly that have a positive overshoot, upright P waves in V1, and inverted P waves in V6.

Electroanatomic map of the posterior left atrium,...Media file 8: Electroanatomic map of the posterior left atrium, illustrating the pulmonary veins: right superior pulmonary vein (RSPV), right inferior pulmonary vein (RIPV), left superior pulmonary vein (LSPV), and left inferior pulmonary vein (LIPV). The red circles represent actual discrete radiofrequency applications, predominantly delivered in a circumferential pattern around the pulmonary veins. This ablation strategy can isolate pulmonary vein foci that initiate atrial fibrillation, and/or alter the substrate of the left atrium to inhibit fibrillatory activity due to reentry. Image courtesy of American College of Cardiology Foundation.
Electroanatomic map of the posterior left atrium,...

Electroanatomic map of the posterior left atrium, illustrating the pulmonary veins: right superior pulmonary vein (RSPV), right inferior pulmonary vein (RIPV), left superior pulmonary vein (LSPV), and left inferior pulmonary vein (LIPV). The red circles represent actual discrete radiofrequency applications, predominantly delivered in a circumferential pattern around the pulmonary veins. This ablation strategy can isolate pulmonary vein foci that initiate atrial fibrillation, and/or alter the substrate of the left atrium to inhibit fibrillatory activity due to reentry. Image courtesy of American College of Cardiology Foundation.

More on Catheter Ablation

References

References

  1. Smith PN, Vidaillet H, Sharma PP, et al. Catheter ablation in the elderly in the United States: use in the Medicare population from 1991 to 1998. Pacing Clin Electrophysiol. Jan 2001;24(1):66-9. [Medline].

  2. Haissaguerre M, Fischer B, Labbe T, et al. Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathways. Am J Cardiol. Feb 15 1992;69(5):493-7. [Medline].

  3. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. Aug 15 2006;114(7):e257-354. [Medline].

  4. Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol. Oct 15 2003;42(8):1493-531. [Medline].

  5. Brignole M, Menozzi C, Gianfranchi L, et al. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. Circulation. Sep 8 1998;98(10):953-60. [Medline].

  6. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. Jun 2007;4(6):816-61. [Medline].

  7. Calkins H, Yong P, Miller JM, et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation. Jan 19 1999;99(2):262-70. [Medline].

  8. Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. Mar 8 2005;111(9):1100-5. [Medline].

  9. Cesario DA, Mahajan A, Shivkumar K. Lesion-forming technologies for catheter ablation of atrial fibrillation. Heart Rhythm. Mar 2007;4(3 Suppl):S44-50. [Medline].

  10. Chen SA, Chiang CE, Tai CT, et al. Complications of diagnostic electrophysiologic studies and radiofrequency catheter ablation in patients with tachyarrhythmias: an eight-year survey of 3,966 consecutive procedures in a tertiary referral center. Am J Cardiol. Jan 1 1996;77(1):41-6. [Medline].

  11. Goette A, Reek S, Klein HU, Geller JC. Case report: severe skin burn at the site of the indifferent electrode after radiofrequency catheter ablation of typical atrial flutter. J Interv Card Electrophysiol. Sep 2001;5(3):337-40. [Medline].

  12. Kimman GP, Theuns DA, Szili-Torok T, et al. CRAVT: a prospective, randomized study comparing transvenous cryothermal and radiofrequency ablation in atrioventricular nodal re-entrant tachycardia. Eur Heart J. Dec 2004;25(24):2232-7. [Medline].

  13. Lee RJ, Kalman JM, Fitzpatrick AP, et al. Radiofrequency catheter modification of the sinus node for "inappropriate" sinus tachycardia. Circulation. Nov 15 1995;92(10):2919-28. [Medline].

  14. Morady F. Radio-frequency ablation as treatment for cardiac arrhythmias. N Engl J Med. Feb 18 1999;340(7):534-44. [Medline].

  15. Natale A, Newby KH, Pisano E, et al. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol. Jun 2000;35(7):1898-904. [Medline].

  16. O'Neill MD, Jaïs P, Hocini M, Sacher F, Klein GJ, Clémenty J. Catheter ablation for atrial fibrillation. Circulation. Sep 25 2007;116(13):1515-23. [Medline].

  17. [Best Evidence] Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med. Mar 2 2006;354(9):934-41. [Medline].

  18. Pappone C, Oral H, Santinelli V, et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation. Jun 8 2004;109(22):2724-6. [Medline].

  19. Perisinakis K, Damilakis J, Theocharopoulos N, et al. Accurate assessment of patient effective radiation dose and associated detriment risk from radiofrequency catheter ablation procedures. Circulation. Jul 3 2001;104(1):58-62. [Medline].

  20. Proclemer A, Della Bella P, Tondo C, et al. Radiofrequency ablation of atrioventricular junction and pacemaker implantation versus modulation of atrioventricular conduction in drug refractory atrial fibrillation. Am J Cardiol. May 15 1999;83(10):1437-42. [Medline].

  21. Szumowski L, Sanders P, Walczak F, et al. Mapping and ablation of polymorphic ventricular tachycardia after myocardial infarction. J Am Coll Cardiol. Oct 19 2004;44(8):1700-6. [Medline].

  22. Tracy CM, Akhtar M, DiMarco JP, et al. American College of Cardiology/American Heart Association Clinical Competence Statement on invasive electrophysiology studies, catheter ablation, and cardioversion: A report of the American College of Cardiology/American Heart Association/American Col. Circulation. Oct 31 2000;102(18):2309-20. [Medline].

  23. [Best Evidence] Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. Jun 1 2005;293(21):2634-40. [Medline].

Further Reading

Keywords

RFCA, radiofrequency ablation, catheter ablation, tachyarrhythmias, tachycardias, supraventricular tachycardia, SVT, orthodromic reciprocating tachycardia, ORT, unifocal atrial tachycardia, ventricular tachycardia, VT, Wolff-Parkinson-White syndrome, WPW syndrome, atrial flutter, atrial fibrillation, atrioventricular nodal reentrant tachycardia, AVNRT, polymorphic ventricular tachycardia, ventricular fibrillation, paroxysmal atrial fibrillation, idiopathic ventricular tachycardia

Contributor Information and Disclosures

Author

Mark Lloyd Greenberg, MD, Director, Clinical Electrophysiology and Pacing, Director, Clinical Cardiac Electrophysiology Training Program, Dartmouth-Hitchcock Medical Center; Associate Professor of Medicine, Dartmouth Medical School
Mark Lloyd Greenberg, MD is a member of the following medical societies: American College of Cardiology, American Heart Association, and American Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Arvind Chandrakantan, MBBS, MD, Anesthetic Fellow, Department of Pediatric Anesthesiology, Cincinnati Children's Medical Center
Disclosure: Nothing to disclose.

Medical Editor

Justin D Pearlman, MD, PhD, ME, MA, Director of Dartmouth Advanced Imaging Center, Professor of Medicine, Professor of Radiology, Adjunct Professor, Thayer Bioengineering and Computer Science, Dartmouth-Hitchcock Medical Center
Justin D Pearlman, MD, PhD, ME, MA is a member of the following medical societies: American College of Cardiology, American College of Physicians, American Federation for Medical Research, International Society for Magnetic Resonance in Medicine, and Radiological Society of North America
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Brian Olshansky, MD, Professor of Medicine, Department of Internal Medicine, University of Iowa College of Medicine
Brian Olshansky, MD is a member of the following medical societies: American Autonomic Society, American College of Cardiology, American College of Chest Physicians, American College of Physicians, American College of Sports Medicine, American Federation for Clinical Research, American Heart Association, Cardiac Electrophysiology Society, Heart Rhythm Society, and New York Academy of Sciences
Disclosure: Guidant/Boston Scientific Honoraria Speaking and teaching; Medtronic Honoraria Speaking and teaching; Guidant/Boston Scientific Consulting fee Consulting; Reliant Grant/research funds Other; Novartis Honoraria Speaking and teaching; Novartis Consulting fee Consulting

CME Editor

Amer Suleman, MD, Consultant in Electrophysiology and Cardiovascular Medicine, Department of Internal Medicine, Division of Cardiology, Medical City Dallas Hospital
Amer Suleman, MD is a member of the following medical societies: American College of Physicians, American Heart Association, American Institute of Stress, American Society of Hypertension, Federation of American Societies for Experimental Biology, Royal Society of Medicine, and Society of Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

Chief Editor

J Paul Mounsey, MD, PhD, MRCP, Professor of Medicine, Director, Cardiac Electrophysiology Service, Division of Cardiology, University of North Carolina
J Paul Mounsey, MD, PhD, MRCP is a member of the following medical societies: American College of Cardiology, American Heart Association, Heart Rhythm Society, and Royal College of Physicians of the United Kingdom
Disclosure: Medtronic Honoraria Speaking and teaching; St Jude Honoraria Speaking and teaching; Boston Scientific Honoraria Speaking and teaching

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.